Marsh & McLennan Companies, Inc.
197.48USD
-1.7900 (-0.90%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MRSH.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 20.7B | 22.7B | 24.5B | 27.0B | 28.7B | 30.1B |
| Q1 | 5.5B | 5.9B | 6.5B | 7.1B | 7.6B | 8.0B |
| Q2 | 5.4B | 5.9B | 6.2B | 7.0B | 7.4B | — |
| Q3 | 4.8B | 5.4B | 5.7B | 6.4B | 6.9B | — |
| Q4 | 5.0B* | 5.6B* | 6.1B* | 6.6B* | 6.9B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 6.04 | 7.53 | 8.18 | 8.43 | 10.49 | 11.46 |
| Q1 | 2.10 | 2.47 | 2.82 | 2.79 | 2.36 | 3.57 |
| Q2 | 1.91 | 2.07 | 2.27 | 2.45 | 2.63 | — |
| Q3 | 1.08 | 1.47 | 1.51 | 1.51 | 1.69 | — |
| Q4 | .923* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| 1.52* |
| 1.59* |
| 1.66* |
| 2.21 |
| — |
Debt level and coverage